Lv69
1930 积分 2022-09-16 加入
Next-Generation Anti-IL-17 Agents for Psoriatic Disease: A Pipeline Review
8天前
已完结
Preclinical Toxicology Supply for a Complex API Enabled by Asymmetric Catalysis and Rapid Chemical Development: IL-17A Inhibitor LY3509754
12天前
已完结
Development of a Scalable Process for an IL-17A Inhibitor LY3509754: Part III. Assembly of Drug Substance, Salt Formation, and Impurity Control
12天前
已完结
Development of a Scalable Process for an IL-17A Inhibitor LY3509754. Part II: Synthesis of the α-Bromoketone Intermediate Leveraging Concomitant Decarboxylation Following Enzymatic Ester Hydrolysis
12天前
已完结
Development of a Scalable Process for an IL-17A Inhibitor LY3509754: Part I: Synthesis of the Pyridazinyl Imidazolidinone Intermediate Enabled by Biocatalysis and CSTR Technologies
12天前
已完结
Next-Generation Anti-IL-17 Agents for Psoriatic Disease: A Pipeline Review
1个月前
已完结
Guidelines for the treatment of psoriasis with biologics and small-molecule drugs in China （2024）
1个月前
已完结
Thiazole‐based IL‐17 inhibitors discovered by scaffold morphing
3个月前
已完结
Advances in immunological mechanisms in allergic contact dermatitis
3个月前
已完结
Discovery and In Vivo Exploration of 1,3,4-Oxadiazole and α-Fluoroacrylate Containing IL-17 Inhibitors
7个月前
已完结
皖公网安备34019202002308
